15 years of revenue, profit, cash flow and balance-sheet history through FY2025, from SEC filings — with a computed, factual read of the trend. Updated Overview →
| FY | Revenue | Net income | Gross M | Op M | FCF | Total debt | Cash |
|---|---|---|---|---|---|---|---|
| 2025 | $191M | -$6M | 24.1% | -3.1% | $7M | $50M | $9M |
| 2024 | $164M | $6M | 25.7% | 6.1% | $15M | $55M | $7M |
| 2023 | $159M | $7M | 24.7% | 6.0% | -$623000 | $26M | $10M |
| 2022 | $132M | -$119000 | 22.3% | 0.1% | -$3M | $21M | $6M |
| 2021 | $98M | -$234000 | 25.1% | 0.0% | $2M | $21M | $8M |
| 2020 | $108M | $5M | 27.1% | 5.3% | $19M | $1M | $11M |
| 2019 | $107M | $5M | 29.2% | 6.9% | -$9M | $17M | $7M |
| 2018 | $87M | $25M | 29.3% | 7.5% | $7M | — | $26M |
| 2017 | $86M | $8M | 30.7% | 7.6% | $6M | — | $18M |
| 2016 | $82M | $4M | 30.4% | 4.6% | $6M | — | $11M |
| 2015 | $76M | $3M | 30.5% | 4.4% | $6M | — | — |
| 2014 | $66M | -$2M | 29.1% | -2.2% | $2M | — | — |
| 2013 | $79M | -$926000 | 28.7% | -0.8% | $6M | — | — |
| 2012 | $102M | -$2M | 28.3% | -0.1% | $2M | — | — |
| 2011 | — | -$2M | — | — | $9M | — | — |
| Quarter | Revenue | Net income | Gross M | Op M | FCF | Total debt | Cash |
|---|---|---|---|---|---|---|---|
| Mar '26 | $47M | -$451000 | 21.3% | -0.5% | $1M | $48M | $9M |
| Dec '25 | $48M | -$7M | 24.9% | -21.9% | $607000 | $50M | $9M |
| Sep '25 | $43M | -$1M | 22.2% | -2.2% | -$797000 | $50M | $9M |
| Jun '25 | $49M | $879000 | 23.9% | 4.6% | $5M | $51M | $11M |
| Mar '25 | $51M | $2M | 25.1% | 6.7% | $2M | $54M | $9M |
| Dec '24 | $44M | $194000 | 24.2% | 3.4% | $2M | $55M | $7M |
| Sep '24 | $36M | $258000 | 24.3% | 1.4% | $4M | $8M | $7M |
| Jun '24 | $43M | $3M | 26.9% | 9.1% | $9M | $12M | $7M |
| Mar '24 | $42M | $3M | 27.4% | 9.7% | -$453000 | $25M | $10M |
| Dec '23 | $45M | $3M | 25.6% | 8.2% | $1M | $26M | $10M |
| Sep '23 | $39M | $1M | 24.8% | 5.4% | -$1M | $26M | $9M |
| Jun '23 | $43M | $3M | 24.8% | 8.6% | $1M | $25M | $8M |
| Mar '23 | $32M | -$346000 | 23.3% | 0.1% | -$2M | $23M | $6M |
| Dec '22 | $36M | -$224000 | 22.4% | 0.6% | $2M | $21M | $6M |
| Sep '22 | $33M | -$239000 | 20.2% | -1.8% | -$1M | $23M | $5M |
| Jun '22 | $32M | $512000 | 23.8% | 2.5% | -$392000 | $22M | $5M |
| Mar '22 | $30M | -$168000 | 22.9% | -1.0% | -$4M | $22M | $6M |
| Dec '21 | $24M | -$1M | 22.3% | -5.2% | -$5M | $21M | $8M |
| Sep '21 | $22M | -$585000 | 23.5% | -3.6% | $408000 | — | $16M |
| Jun '21 | $27M | $811000 | 27.1% | 4.1% | $2M | — | $16M |
How the market has priced ULBI against its own fundamentals since 2023-03 — each month-end's share price set against the most recent annual filing, so the multiple moves as price runs ahead of (or behind) earnings. Split-adjusted.
Over the past 5 years, ULTRALIFE CORP's revenue has grown 12.2% per year. These are computed facts, not advice.
As of FY2025, ULTRALIFE CORP reported $50M of total debt against $9M of cash; operating income covered interest expense -1.5×.
In FY2025, gross margin was 24.1%, operating margin -3.1%, and net margin -3.1%.
As of Jun '26, ULTRALIFE CORP traded at a price-to-earnings ratio of about 15.1× (market cap ÷ latest annual net income). The valuation charts above show how its P/E, P/S have moved with the share price. These are computed facts, not advice.
All figures are extracted from the company’s SEC EDGAR/XBRL filings — 10-K annual reports and 10-Q quarterly reports (use the Annual / Quarterly toggle). Quarterly figures are derived from the as-filed statements (year-to-date amounts are differenced into discrete quarters). Growth rates and ratios are computed by tradmap; nothing here is investment advice.
Source: SEC EDGAR / XBRL (10-K + 10-Q filings) · prices EOD (Databento), corporate-action-adjusted · growth rates, valuation multiples & ratios computed by tradmap. Valuation uses each month-end price against the latest annual filing. Informational only — not investment advice.